Related references
Note: Only part of the references are listed.Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious
Mark D. Muthiah et al.
HEPATOLOGY INTERNATIONAL (2020)
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
Riccardo Volpes et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Higher proportion of responders with hepatitis B antibody levels ≥ 100 miu/ml with the trivalent HepB vaccine, Sci-B-Vac, compared to Engerix-B: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety (PROTECT)
Timo Vesikari et al.
JOURNAL OF HEPATOLOGY (2020)
Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
Tiffany Cho-Lam Wong et al.
JOURNAL OF HEPATOLOGY (2019)
New treatment options for delta virus: Is a cure in sight?
Cihan Yurdaydin
JOURNAL OF VIRAL HEPATITIS (2019)
Long-term consequences of stopping HBIG and/or nucleotide analogues in liver transplant recipients administered hepatitis B vaccination to prevent HBV reinfection
Bin-Wei Duan et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Long-term outcomes with oral therapy in liver transplant recipients with hepatitis B
Sammy Saab et al.
CLINICAL TRANSPLANTATION (2019)
Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation
Wei-Chen Lee et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
Shin Hwang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2019)
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal
Matteo A. Manini et al.
DIGESTIVE AND LIVER DISEASE (2018)
Evaluation of renal and bone safety in post liver transplant patients with chronic kidney disease receiving Tenofovir Alafenamide for HBV prophylaxis
E. Gane et al.
JOURNAL OF HEPATOLOGY (2018)
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection
Gian Paolo Caviglia et al.
JOURNAL OF HEPATOLOGY (2018)
Deep sequencing shows low-level oncogenic hepatitis B virus variants persists post-liver transplant despite potent anti-HBV prophylaxis
K. C. K. Lau et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation
W. -C. Lee et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population
Lai Wei et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
Sabela Lens et al.
LIVER INTERNATIONAL (2018)
Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study
Rob Bielen et al.
TRANSPLANT INTERNATIONAL (2018)
Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection
Lindsey M. Childs-Kean et al.
PHARMACOTHERAPY (2018)
Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation
Abhinav Vasudevan et al.
JGH OPEN (2018)
Management of chronic hepatitis B before and after liver transplantation
B. Wang et al.
FRONTLINE GASTROENTEROLOGY (2018)
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
Susanne Beckebaum et al.
ANNALS OF TRANSPLANTATION (2018)
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation
Visagh Puthumana Udayakumar et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2018)
Long-Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years
James Fung et al.
HEPATOLOGY (2017)
Active Immunization for Prevention of De Novo Hepatitis B Virus Infection After Adult Living Donor Liver Transplantation With a Hepatitis B Core Antigen-Positive Graft
Shih-Ho Wang et al.
LIVER TRANSPLANTATION (2017)
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
Kavita Radhakrishnan et al.
TRANSPLANTATION (2017)
Effect of Dosage and Type of Hepatitis B Immunoglobulin on Hepatitis Antibody Levels in Liver Transplant Recipients
A. Ulku et al.
TRANSPLANTATION PROCEEDINGS (2017)
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors
Roberto Ballarin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study
Anli Yang et al.
PLOS ONE (2017)
A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
Ho Joong Choi et al.
ANNALS OF TRANSPLANTATION (2017)
Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts
Atsushi Yoshizawa et al.
HEPATOLOGY RESEARCH (2016)
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
Ramazan Idilman et al.
CLINICAL TRANSPLANTATION (2016)
The Management of Hepatitis B in Liver Transplant Recipients
Sammy Saab et al.
CLINICS IN LIVER DISEASE (2016)
Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative
Lei Geng et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET (2016)
Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression
Ilaria Lenci et al.
LIVER TRANSPLANTATION (2016)
De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers
Sanghoon Lee et al.
LIVER TRANSPLANTATION (2016)
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
Paolo De Simone et al.
TRANSPLANTATION (2016)
Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus
B. Adil et al.
TRANSPLANTATION PROCEEDINGS (2016)
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature
Elisabetta Loggi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management
S. Huprikar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients
Gang Chen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation
Winston Ku et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
Rahim Rahimi et al.
HEPATITIS MONTHLY (2015)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Outcomes Including Liver Histology After Liver Transplantation for Chronic Hepatitis B Using Oral Antiviral Therapy Alone
James Fung et al.
LIVER TRANSPLANTATION (2015)
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
I. Fernandez et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience
A. T. Akcam et al.
TRANSPLANTATION PROCEEDINGS (2015)
Limited Hepatitis B Immunoglobulin With Potent Nucleos(t)ide Analogue Is a Cost-Effective Prophylaxis Against Hepatitis B Virus After Liver Transplantation
G. A. Singer et al.
TRANSPLANTATION PROCEEDINGS (2015)
Prophylaxis against hepatitis B virus recurrence after liver transplantation: A registry study
Shu Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative
Eva Hulstaert et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2015)
Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation
Songfeng Yu et al.
JOURNAL OF HEPATOLOGY (2014)
Use of Hepatitis B Surface Antigen-Positive Grafts in Liver Transplantation: A Matched Analysis of the US National Database
Zhiwei Li et al.
LIVER TRANSPLANTATION (2014)
Frequent Incidence of Escape Mutants After Successful Hepatitis B Vaccine Response and Stopping of Nucleos(t)ide Analogues in Liver Transplant Recipients
Masatoshi Ishigami et al.
LIVER TRANSPLANTATION (2014)
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Peijie Wang et al.
PLOS ONE (2014)
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome
Tahereh Ghaziani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Anti-HBc-positive/HBsAg-negative liver donors pose a higher risk of occult HBV infection but do not cause severe histological damage in liver grafts
Yujian Niu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
Shi-Chun Lu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation
Tomohiro Tanaka et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Safety and Efficacy of Subcutaneous Hepatitis B Immunoglobulin After Liver Transplantation: An Open Single-Arm Prospective Study
G. G. Di Costanzo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Allografts Positive for Hepatitis B Surface Antigen in Liver Transplant for Disease Related to Hepatitis B Virus
Weiqiang Ju et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2013)
Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective
D. J. W. Wesdorp et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin
Nam-Joon Yi et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Akinobu Takaki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2013)
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
Robert Perrillo et al.
LIVER TRANSPLANTATION (2013)
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis
Manav Wadhawan et al.
LIVER TRANSPLANTATION (2013)
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
Lewis W. Teperman et al.
LIVER TRANSPLANTATION (2013)
Liver Transplantation From Hepatitis B Surface Antigen-Positive Donors
R. F. Saidi et al.
TRANSPLANTATION PROCEEDINGS (2013)
Hepatitis B Prophylaxis Using Lamivudine and Individualized Low-dose Hepatitis B Immunoglobulin in Living Donor Liver Transplantation
L. Jiang et al.
TRANSPLANTATION PROCEEDINGS (2013)
Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation
Evangelos Cholongitas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool
Elisabetta Loggi et al.
JOURNAL OF HEPATOLOGY (2012)
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
Ingmar Mederacke et al.
JOURNAL OF HEPATOLOGY (2012)
Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients
Monica Franciosi et al.
LIVER TRANSPLANTATION (2012)
Clinical Features of Hepatitis D
Patrizia Farci et al.
SEMINARS IN LIVER DISEASE (2012)
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts
Masatoshi Ishigami et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Posttransplantation Prophylaxis With Primary High-Dose Hepatitis B Immunoglobulin Monotherapy and Complementary Preemptive Antiviral Add-On
Shin Hwang et al.
LIVER TRANSPLANTATION (2011)
Hepatitis B Immunoglobulin and/or Nucleos(t)ide Analogues for Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
Evangelos Cholongitas et al.
LIVER TRANSPLANTATION (2011)
Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra®) in liver transplantation: an open, prospective, single-arm phase III study
Ali Yahyazadeh et al.
TRANSPLANT INTERNATIONAL (2011)
Long-Term Results of Hepatitis B Immunoglobulin and Lamuvidine for Hepatitis B Prophylaxis After Liver Transplantation
S. Sevmis et al.
TRANSPLANTATION PROCEEDINGS (2011)
Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient
Ralf Bahde et al.
ANNALS OF HEPATOLOGY (2011)
Efficacy, safety, and pharmacokinetics of intramuscular hepatitis B immune globulin, Igantibe®, for the prophylaxis of viral B hepatitis after liver transplantation
Franco Filipponi et al.
DIGESTIVE AND LIVER DISEASE (2010)
Liver grafts from anti-hepatitis B core positive donors: A systematic review
Evangelos Cholongitas et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
L. H. Katz et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence
Janakie Singham et al.
ANNALS OF HEPATOLOGY (2010)
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
Elisabetta Loggi et al.
JOURNAL OF HEPATOLOGY (2009)
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
A. Mas et al.
TRANSPLANTATION PROCEEDINGS (2009)
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
George V. Popotheodoridis et al.
LANCET INFECTIOUS DISEASES (2008)
Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection
Lucio Caccamo et al.
TRANSPLANTATION (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection
A Franchello et al.
LIVER TRANSPLANTATION (2005)
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
A Marzano et al.
LIVER TRANSPLANTATION (2005)
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis
B Roche et al.
HEPATOLOGY (2003)
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era
GV Papatheodoridis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review
D Shouval et al.
HEPATOLOGY (2000)
Share Paper
